September, 24-28, Rhode Island, USA.
We will be exhibiting at the 21st North American ISSX Meeting 2017 in Rhode Island, on 24-28 September.
Find us at booth 405 and speak to Iain Shaw, Director, 14-C Enabled Drug Development.
We will also be presenting a poster, co-published with Teva Pharmaceuticals evaluating the in vivo disposition of a novel deuterated compound.
Poster title: An Open-label, Two-period Study Designed to Evaluate and Compare the Mass Balance Recovery and Metabolite Profile of 14C-Deutetrabenazine and 14C-Tetrabenazine in Healthy Male Subjects
Poster No – 168, Session 3, 1pm – 2pm, Wednesday, September 27th
If you have any questions please contact Iain Shaw.